You are here

  • Home
  • Archive
  • Volume 34, Issue 3
  • Medicolegal, infrastructural, and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?

Article Text

Article menu
Download PDFPDF
Review
Medicolegal, infrastructural, and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?
  1. Emma Allanson1,
  2. Anjali Hari2,
  3. Edgard Ndaboine3,
  4. Paul A Cohen1 and
  5. Robert Bristow2
    1. 1 Division of Obstetrics and Gynaecology, Medical School, The University of Western Australia, Perth, Western Australia, Australia
    2. 2 Division of Gynecologic Oncology, University of California Irvine, Orange, California, USA
    3. 3 Department of Obstetrics & Gynecology, Catholic University of Health and Allied Sciences, Mwanza, Mwanza, Tanzania
    1. Correspondence to Professor Paul A Cohen, Division of Obstetrics and Gynaecology, Medical School, The University of Western Australia, Perth, WA 6009, Australia; paul.cohen{at}uwa.edu.au

    Abstract

    Surgical decision making is complex and involves a combination of analytic, intuitive, and cognitive processes. Medicolegal, infrastructural, and financial factors may influence these processes depending on the context and setting, but to what extent can they influence surgical decision making in gynecologic oncology? This scoping review evaluates existing literature related to medicolegal, infrastructural, and financial aspects of gynecologic cancer surgery and their implications in surgical decision making. Our objective was to summarize the findings and limitations of published research, identify gaps in the literature, and make recommendations for future research to inform policy.

    • Gynecologic Surgical Procedures

    https://doi.org/10.1136/ijgc-2023-004585

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      View Full Text

      Footnotes

      • PAC and RB are joint senior authors.

      • Contributors All authors contributed to the conception, writing, and editing of the manuscript.

      • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

      • Competing interests PAC declares honoraria from Astra Zeneca unrelated to the submitted work.

      • Provenance and peer review Commissioned; externally peer reviewed.

      • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

      Linked Articles